Dicloxacillin clinical trials
Dicloxacillin is named as an intervention in 3 current clinical trials in our Spain, Denmark and Israel registers. 3 are recruiting patients now. The most common phase is Phase 4. The sponsor with the most trials is Fundacion Clinic per a la Recerca Biomédica (1). The most-studied condition is Endocarditis Infective. The EU clinical trials register (CTIS) separately lists 1 authorised or ongoing trial.
Where Dicloxacillin is approved
All regulators →Of the three regulators tracked here, the first to approve Dicloxacillin was the US, on 22 Apr 1968.
From the regulators' own registers: FDA Drugs@FDA, the EMA medicines list and Health Canada's Notice of Compliance database. Dates are the first listed approval of a product containing only this substance; combination products and nationally authorised EU medicines are not counted.
What health systems spend on Dicloxacillin
All medicines →From NHSBSA Prescription Cost Analysis (Open Government Licence v3.0) and CMS State Drug Utilization Data. Both are gross amounts: neither system publishes its discounts or rebates per drug. Products combining several substances are not counted here.
How Dicloxacillin works
All drug targets →- Penicillin-binding protein inhibitor InhibitorChEMBL only
Mechanisms and diseases from ChEMBL via the Open Targets Platform (release 26.09), ChEMBL record CHEMBL893, CC BY-SA 3.0. Targets checked against the IUPHAR/BPS Guide to PHARMACOLOGY (2026.3.1), ligand 12261, CC BY-SA 4.0. Trial phases are not approvals: approved uses are shown from the regulators' own records where we hold them.
Patient leaflets for Dicloxacillin
The package leaflet is the official guide for patients that comes with every medicine. These links go to the regulators that publish it.
- UKUnited Kingdom: Search MHRA ProductsPatient information leaflets and SmPCs for UK-licensed products.
- USUnited States: Search DailyMedFDA-approved labels, including patient and medication guides.
Leaflets differ between brands and countries; always read the one that comes with your own medicine. This is regulatory information, not medical advice.
Reference identifiers for Dicloxacillin
- ATC code
- J01CF01
- ChEMBL
- CHEMBL893
- DrugBank
- DB00485
- PubChem CID
- 18381
- CAS number
- 3116-76-5
- FDA UNII
- COF19H7WBK
- Wikidata
- Q2313471
- Wikipedia
- Dicloxacillin
Codes that identify this medicine in other databases, from Wikidata (CC0), matched by its ChEMBL ID. The ATC code is the WHO classification of what the medicine is used for.
Trials by status
Trials by phase
Clinical trials of Dicloxacillin
3 trials| Study | Phase | Status | Lead sponsor | Registers |
|---|---|---|---|---|
|
Oral Antimicrobial Treatment vs. Outpatient Parenteral for Infective Endocarditis
NCT05398679 · ClinicalTrials.gov ↗ · Endocarditis Infective
|
Phase 4 | Recruiting | Fundacion Clinic per a la Recerca Biomédica | Spain |
|
Antibiotic Tissue Penetration and Tissue Response in Head and Neck Infection and Reconstructive Surgery
NCT07896239 · ClinicalTrials.gov ↗ · Surgical Wound Infection, Neck Infection, Nasal Reconstruction
|
Phase 4 | Recruiting | Tejs Ehlers Klug | Denmark |
|
Determinants of Warfarin Metabolism
NCT00162474 · ClinicalTrials.gov ↗ · Healthy
|
Not applicable | Recruiting | Hadassah Medical Organization | Israel |
Registers list studies that are recruiting, about to open, active but closed to enrolment, or enrolling by invitation. The UK and USA registers cover industry-sponsored studies only. Trial titles and statuses are copied from the registry as published.
Dicloxacillin in the EU trials register (CTIS)
1 trialAuthorised or ongoing trials in the EU Clinical Trials Information System that list a product containing Dicloxacillin. Many trials are registered in both CTIS and ClinicalTrials.gov, so these are shown separately rather than added to the count above. Trials with a site in Ireland are listed first.
| Study | Phase | Status | Sponsor | Countries |
|---|---|---|---|---|
|
Antibiotikapenetration og vævsrespons ved infektion og rekonstruktiv kirurgi i hoved-hals regionen
2026-526995-22-00 · Bacterial Infections and Mycoses
|
Phase 3 | Authorised | Region Midtjylland | Denmark |
Conditions studied with Dicloxacillin
5 conditionsSponsors
lead sponsor per trial| Lead sponsor | Trials |
|---|---|
| Fundacion Clinic per a la Recerca Biomédica | 1 |
| Tejs Ehlers Klug | 1 |
| Hadassah Medical Organization | 1 |
By country register
| Register | Trials | Recruiting |
|---|---|---|
| Clinical trials in Spain | 1 | 1 |
| Clinical trials in Denmark | 1 | 1 |
| Clinical trials in Israel | 1 | 1 |
| EU register (CTIS) | 1 | — |
A trial with sites in more than one country appears in each of those registers. CTIS does not publish a recruiting flag; its trials may also appear in the registers above.
Related compounds
Questions about Dicloxacillin trials
How many clinical trials are testing Dicloxacillin?
3 current trials in our Spain, Denmark and Israel registers name Dicloxacillin as a drug or biological intervention, as of the registry sync on 12 November 2026. Completed and withdrawn studies are not counted.
Are Dicloxacillin trials recruiting patients?
Yes. 3 of the 3 trials are recruiting: 1 with sites in Spain, 1 with sites in Denmark and 1 with sites in Israel. Eligibility and site contacts are on each trial's record. Only the study team can confirm whether a patient is eligible.
Who sponsors Dicloxacillin clinical trials?
Fundacion Clinic per a la Recerca Biomédica (1), Tejs Ehlers Klug (1) and Hadassah Medical Organization (1). The number in brackets is how many trials each organisation leads.
Where does this information come from?
Every trial, status, phase and sponsor on this page is copied from public ClinicalTrials.gov records by a daily sync. Nothing here describes how Dicloxacillin works or whether it is effective, and it is not medical advice.
How this page is built
Everything on this page is copied from public ClinicalTrials.gov registry records — it is not written from memory, and nothing here describes how Dicloxacillin works or whether it is effective. Each trial links to its own record so you can check it yourself.
- ClinicalTrials.gov (U.S. National Library of Medicine) ↗ Trial IDs, titles, intervention names and synonyms, phase, overall status, lead sponsor and conditions for every trial on this page
This page is built automatically: a daily sync job reads the registry records behind our country trial registers, collects every trial that lists Dicloxacillin (or a registered synonym) as a drug or biological intervention, and tabulates the registry fields directly. Placebos and generic comparators are excluded. There is no AI drafting and no per-compound editorial pass, and the page has not been clinically reviewed. The “last verified” date above is the timestamp of that sync, not a review date. Our general editorial approach is described in our editorial standards and corrections policy. The ClinicalTrials.gov data on this page was last retrieved on 12 Nov 2026. How every register is built: methodology · fixes we have made: corrections log.